FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and the pharmaceutical industry and describes a pharmaceutical inhaled medication for treatment of bronchial asthma and chronic obstructive lung disease, containing micronised tiotropium bromide as an active substance, and which contains as a carrier lactose with the average particle size of 120-200 mcm, sodium benzoate, sieved with a bulk density within the range of 0.30-0.50 g/cm3 and sodium benzoate micronised with the average particle size of 0.5-10 mcm with a specified content of components per a dose of medication.
EFFECT: invention provides higher percent of a respirable fraction of the active substance and, therefore, higher pharmacological activity.
3 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHALATION PREPARATION FOR TREATING BRONCHAIL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2504382C1 |
| INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT | 2012 |
|
RU2494730C1 |
| INHALATION PREPARATION FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2510267C2 |
| IPRATROPIUM BROMIDE SOLUTION | 2012 |
|
RU2496477C1 |
| STABLE COMBINED SOLUTION OF FENOTEROL HYDROBROMIDE AND IPRATROPIUM BROMIDE | 2012 |
|
RU2493827C1 |
| FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
| AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
| PHARMACEUTICAL COMPOSITION FOR INHALATION | 2006 |
|
RU2338552C2 |
| STABLE SOLUTION OF FENOTEROL HYDROBROMIDE | 2012 |
|
RU2479304C1 |
| COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385721C2 |
